Enanta Pharmaceuticals Statistics
Total Valuation
ENTA has a market cap or net worth of $281.80 million. The enterprise value is -$33.83 million.
| Market Cap | 281.80M |
| Enterprise Value | -33.83M |
Important Dates
The next estimated earnings date is Monday, May 6, 2024, after market close.
| Earnings Date | May 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ENTA has 21.16 million shares outstanding. The number of shares has increased by 1.31% in one year.
| Shares Outstanding | 21.16M |
| Shares Change (YoY) | +1.31% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | 6.10% |
| Owned by Institutions (%) | 100.30% |
| Float | 13.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.83 |
| Forward PS | 3.97 |
| PB Ratio | 1.47 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.25, with a Debt / Equity ratio of 0.13.
| Current Ratio | 6.25 |
| Quick Ratio | 5.60 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -14.83 |
Financial Efficiency
Return on equity (ROE) is -60.40% and return on invested capital (ROIC) is -65.36%.
| Return on Equity (ROE) | -60.40% |
| Return on Assets (ROA) | -32.30% |
| Return on Capital (ROIC) | -65.36% |
| Revenue Per Employee | $507,738 |
| Profits Per Employee | -$953,359 |
| Employee Count | 145 |
| Asset Turnover | 0.17 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ENTA has paid $2.23 million in taxes.
| Income Tax | 2.23M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.25% in the last 52 weeks. The beta is 0.49, so ENTA's price volatility has been lower than the market average.
| Beta (1Y) | 0.49 |
| 52-Week Price Change | -64.25% |
| 50-Day Moving Average | 14.70 |
| 200-Day Moving Average | 13.02 |
| Relative Strength Index (RSI) | 35.58 |
| Average Volume (30 Days) | 238,067 |
Short Selling Information
The latest short interest is 2.74 million, so 12.97% of the outstanding shares have been sold short.
| Short Interest | 2.74M |
| Short Previous Month | 2.41M |
| Short % of Shares Out | 12.97% |
| Short % of Float | 20.56% |
| Short Ratio (days to cover) | 10.82 |
Income Statement
In the last 12 months, ENTA had revenue of $73.62 million and -$138.24 million in losses. Loss per share was -$6.56.
| Revenue | 73.62M |
| Gross Profit | 73.62M |
| Operating Income | -142.08M |
| Pretax Income | -136.00M |
| Net Income | -138.24M |
| EBITDA | -124.91M |
| EBIT | -127.42M |
| Loss Per Share | -$6.56 |
Balance Sheet
The company has $341.12 million in cash and $25.49 million in debt, giving a net cash position of $315.63 million or $14.92 per share.
| Cash & Cash Equivalents | 341.12M |
| Total Debt | 25.49M |
| Net Cash | 315.63M |
| Net Cash Per Share | $14.92 |
| Equity / Book Value | 191.88M |
| Book Value Per Share | 9.07 |
| Working Capital | 327.90M |
Cash Flow
In the last 12 months, operating cash flow was -$92.50 million and capital expenditures -$6.69 million, giving a free cash flow of -$99.19 million.
| Operating Cash Flow | -92.50M |
| Capital Expenditures | -6.69M |
| Free Cash Flow | -99.19M |
| FCF Per Share | -$4.70 |
Margins
Gross margin is 100.00%, with operating and profit margins of -192.99% and -187.77%.
| Gross Margin | 100.00% |
| Operating Margin | -192.99% |
| Pretax Margin | -184.73% |
| Profit Margin | -187.77% |
| EBITDA Margin | -169.67% |
| EBIT Margin | -173.07% |
| FCF Margin | -134.73% |
Dividends & Yields
ENTA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.31% |
| Shareholder Yield | -1.31% |
| Earnings Yield | -49.06% |
| FCF Yield | -35.20% |
Analyst Forecast
The average price target for ENTA is $19.33, which is 45.12% higher than the current price. The consensus rating is "Hold".
| Price Target | $19.33 |
| Price Target Difference | 45.12% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | -1.69% |
| EPS Growth Forecast (5Y) | -13.21% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ENTA has an Altman Z-Score of 0.04 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.04 |
| Piotroski F-Score | 2 |